Junfeng Li - Dept Gastroenterol, Chongqing Med Univ

基本信息

浏览量：0

职业迁徙

个人简介

暂无内容

研究兴趣

论文共 12 篇作者统计合作学者相似作者

按年份排序按引用量排序主题筛选期刊级别筛选合作者筛选合作机构筛选

Tumor Suppressor CLCA1 Inhibits Angiogenesis Via TGFB1/SMAD/VEGF Cascade and Sensitizes Hepatocellular Carcinoma Cells to Sorafenib

Jin He, Fan Wu,Junfeng Li,Qianxi Deng,Jun Chen, Pengtao Li,Xianyao Jiang,Kun Yang,Shuman Xu,Zhongxiang Jiang,Xiaoqing Li,Zheng Jiang

DIGESTIVE AND LIVER DISEASE（2024）

引用0浏览0WOS引用

Single-Cell RNA Sequencing Reveals Intratumoral Heterogeneity and Multicellular Community in Primary Hepatocellular Carcinoma Underlying Microvascular Invasion

Zhuoya Sun,Biao Gao, Lai Song, Biying Wang,Junfeng Li, Hao Jiang,Xuerui Li,Yang Yu,Zishan Zhou,Zizhong Yang, Xiaohui Sun,Tianyu Jiao,Xiao Zhao,Shichun Lu,Shunchang Jiao

Heliyonno. 18 (2024): e37233-e37233

引用0浏览0WOS引用

CCL5/CCR5/CYP1A1 Pathway Prompts Liver Cancer Cells to Survive in the Combination of Targeted and Immunological Therapies

Yafei Wang,Biao Gao,Tianyu Jiao,Wenwen Zhang,Huizhong Shi, Hao Jiang,Xuerui Li,Junfeng Li,Xinlan Ge,Ke Pan,Chonghui Li,Guankun Mao,Shichun Lu

Cancer scienceno. 11 (2024): 3552-3569

引用0浏览0WOS引用

Tumour Suppressor ABCA8 Inhibits Malignant Progression of Colorectal Cancer Via Wnt/β-catenin Pathway

Kun Yang, Xiaolu Li,Zhongxiang Jiang,Junfeng Li,Qianxi Deng,Jin He,Jun Chen,Xiaoqing Li,Shuman Xu,Zheng Jiang

DIGESTIVE AND LIVER DISEASE（2024）

引用0浏览0WOS引用

Effect of CHRDL1 on Angiogenesis and Metastasis of Colorectal Cancer Cells Via TGF-β/VEGF Pathway

Junfeng Li,Zhongxiang Jiang,Jin He,Kun Yang,Jun Chen,Qianxi Deng,Xiaoqing Li,Fan Wu,Shuman Xu,Zheng Jiang

MOLECULAR CARCINOGENESISno. 6 (2024): 1092-1105

引用0浏览0WOS引用

PRELP Inhibits Colorectal Cancer Progression by Suppressing Epithelial-Mesenchymal Transition and Angiogenesis Via the Inactivation of the FGF1/PI3K/AKT Pathway

Xiaoqing Li,Zhongxiang Jiang,Junfeng Li,Kun Yang,Jin He,Qianxi Deng,Shuman Xu, Zhihang Jiang,Fuqiang Liu,Zheng Jiang

APOPTOSIS (2024)

引用0浏览0WOS引用

Lenvatinib Plus Anti-Pd-1 Antibodies As Conversion Therapy for Patients with Unresectable Intermediate-Advanced Hepatocellular Carcinoma: a Single-Arm, Phase II Trial

Journal for immunotherapy of cancerno. 9 (2023): e007366-e007366

引用0浏览0WOS引用

Comparison of Survival Benefit Between Salvage Surgery after Conversion Therapy Versus Surgery Alone for Hepatocellular Carcinoma with Portal Vein Tumor Thrombosis: a Propensity Score Analysis

Yinbiao Cao,Haowen Tang,Bingyang Hu,Wenwen Zhang,Tao Wan, Jun Han,Tianyu Jiao,Junfeng Li,Xuerui Li,Zhanyu Yang, Zhe Liu,Minggen Hu,Weidong Duan,Chenggang Li,Zhiming Zhao,Shichun Lu

HPB the official journal of the International Hepato Pancreato Biliary Associationno. 7 (2023): 775-787

引用1浏览0WOS引用

Efficacy of Treatment Based on TKIs in Combination with PD-1 Inhibitors for Unresectable Recurrent Hepatocellular Carcinoma

Ze Zhang,Tianyu Jiao,Junfeng Li,Bingyang Hu,Wenwen Zhang,Zhijun Wang,Tao Wan,Yafei Wang,Shichun Lu

World Journal of Surgical Oncologyno. 1 (2023)

引用0浏览0WOS引用

Effect of STK3 on proliferation and apoptosis of pancreatic cancer cells via PI3K/AKT/mTOR pathway

Jun Chen,Fuqiang Liu,Jiao Wu,Yichun Yang,Jin He,Fan Wu,Kun Yang,Junfeng Li,Zhongxiang Jiang,Zheng Jiang

Cell Signal（2023）

引用1浏览0WOS引用

加载更多

作者统计

合作学者

合作机构

D-Core

合作者
学生
导师

暂无相似学者，你可以通过学者研究领域进行搜索筛选

数据免责声明

页面数据均来自互联网公开来源、合作出版商和通过AI技术自动分析结果，我们不对页面数据的有效性、准确性、正确性、可靠性、完整性和及时性做出任何承诺和保证。若有疑问，可以通过电子邮件方式联系我们：report@aminer.cn